Prosecution Insights
Prosecution Insights
9 pending office actions • 8 art units • 8 examiners • 0 of 9 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 7 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 7 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (11%) |
| §102 only | 1 (11%) |
| Double-patenting + other | 4 (44%) |
| Multi-statute (no §101) | 3 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DABKOWSKI, ERINNE R | 2 | 55.9% | +69.2% |
| BOECKELMAN, JACOB A | 1 | 36.1% | +46.1% |
| REYNOLDS, FRED H | 1 | 33.1% | +39.0% |
| DAVIS, RUTH A | 1 | 60.8% | +31.2% |
| CHEONG, CHEOM-GIL | 1 | 65.0% | +54.0% |
| YAO, LEI | 1 | 59.8% | +65.4% |
| PRAGANI, RAJAN | 1 | 50.0% | +72.5% |
| MENON, KRISHNAN S | 1 | 59.8% | +11.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18252995 | WOUND HEALING | DAVIS, RUTH A | 87d overdue |
| 18557828 | USE OF THERAPEUTIC PLASMA EXCHANGE AND LOW VOLUME PLASMA EXCHANGE FOR THE TREATMENT OF A COGNITIVE IMPAIRMENT | BOECKELMAN, JACOB A | 49d overdue |
| 18000380 | HYPERIMMUNE IGG AND/OR IGM COMPOSITIONS AND METHOD FOR PREPARING THEREOF AND METHOD FOR OBTAINING HYPERIMMUNE HUMAN PLASMA FROM A DONOR | YAO, LEI | 78d |
| 17757619 | BONE COMPOSITE AND COMPOSITIONS FOR PREPARING SAME | PRAGANI, RAJAN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18252995 | WOUND HEALING | DAVIS, RUTH A | 87d overdue |
| 18557828 | USE OF THERAPEUTIC PLASMA EXCHANGE AND LOW VOLUME PLASMA EXCHANGE FOR THE TREATMENT OF A COGNITIVE IMPAIRMENT | BOECKELMAN, JACOB A | 49d overdue |
| 18002245 | METHOD FOR OBTAINING A COMPOSITION COMPRISING HUMAN PLASMA-DERIVED IMMUNOGLOBULIN M | CHEONG, CHEOM-GIL | 10d overdue |
| 18543196 | USE OF LOW VOLUME PLASMA EXCHANGE FOR TREATING THE EARLY AND MIDDLE STAGES OF ALZHEIMER'S DISEASE | DABKOWSKI, ERINNE R | 7d |
| 18548545 | ALPHA-1 ANTITRYPSIN DOSING REGIMEN | REYNOLDS, FRED H | 60d |
| 18004231 | COMPOSITIONS HAVING NEUROREGENERATIVE APPLICATIONS | DABKOWSKI, ERINNE R | 75d |
| 18000380 | HYPERIMMUNE IGG AND/OR IGM COMPOSITIONS AND METHOD FOR PREPARING THEREOF AND METHOD FOR OBTAINING HYPERIMMUNE HUMAN PLASMA FROM A DONOR | YAO, LEI | 78d |
| 17757619 | BONE COMPOSITE AND COMPOSITIONS FOR PREPARING SAME | PRAGANI, RAJAN | — |
| Art Unit | Apps |
|---|---|
| 1654 | 2 |
| 1655 | 1 |
| 1658 | 1 |
| 1699 | 1 |
| 1645 | 1 |
| 1642 | 1 |
| 1614 | 1 |
| 1777 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18543196 | USE OF LOW VOLUME PLASMA EXCHANGE FOR TREATING THE EARLY AND MIDDLE STAGES OF ALZHEIMER'S DISEASE | DABKOWSKI, ERINNE R | 1654 | §102DP | Final Rejection | 7d | Pending | Dec 18, 2023 |
| 18557828 | USE OF THERAPEUTIC PLASMA EXCHANGE AND LOW VOLUME PLASMA EXCHANGE FOR THE TREATMENT OF A COGNITIVE IMPAIRMENT | BOECKELMAN, JACOB A | 1655 | §102§103§112 | Non-Final OA | 49d overdue | Pending | Oct 27, 2023 |
| 18548545 | ALPHA-1 ANTITRYPSIN DOSING REGIMEN | REYNOLDS, FRED H | 1658 | §103§112DPOther | Non-Final OA | 60d | Pending | Aug 31, 2023 |
| 18252995 | WOUND HEALING | DAVIS, RUTH A | 1699 | §103§112 | Final Rejection | 87d overdue | Pending | May 15, 2023 |
| 18004231 | COMPOSITIONS HAVING NEUROREGENERATIVE APPLICATIONS | DABKOWSKI, ERINNE R | 1654 | §102DPOther | Non-Final OA | 75d | Pending | Jan 04, 2023 |
| 18002245 | METHOD FOR OBTAINING A COMPOSITION COMPRISING HUMAN PLASMA-DERIVED IMMUNOGLOBULIN M | CHEONG, CHEOM-GIL | 1645 | §112DP | Final Rejection | 10d overdue | Pending | Dec 16, 2022 |
| 18000380 | HYPERIMMUNE IGG AND/OR IGM COMPOSITIONS AND METHOD FOR PREPARING THEREOF AND METHOD FOR OBTAINING HYPERIMMUNE HUMAN PLASMA FROM A DONOR | YAO, LEI | 1642 | §101§102§103 | Non-Final OA | 78d | Pending | Nov 30, 2022 |
| 17757619 | BONE COMPOSITE AND COMPOSITIONS FOR PREPARING SAME | PRAGANI, RAJAN | 1614 | §103§112 | Non-Final OA | — | Pending | Jun 17, 2022 |
| 17631819 | METHOD FOR CONTROLLING THE AMOUNT OF ANTICOAGULANT PRESENT IN COLLECTED PLASMA AFTER APHERESIS | MENON, KRISHNAN S | 1777 | §102 | Final Rejection | — | Pending | Jan 31, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial